A nurse recently administered filgrastim intravenously to a client who has ccer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?

The nurse flushed the client's IV line with dextrose 5% in water before and after the medication was administered.

The client's absolute neutrophil count was 2.500/mm3 before the medication was administered.

The client had chemotherapy 12 hr before the medication was administered.

The medication vial sat at room temperature for 2 hr before it was administered.

Answer and Explanation

The Correct Answer is C

A: Flushing an IV line with dextrose 5% in water before and after medication administration is a common practice to ensure that the medication is delivered properly and to prevent interactions in the IV line. This would not typically require an incident report.
B: An absolute neutrophil count of 2.500/mm3 is within the normal range for patients undergoing chemotherapy and would not typically necessitate an incident report.
C: Having chemotherapy 12 hours before the administration of filgrastim does not contraindicate its use and is within the appropriate time frame as filgrastim is often given after chemotherapy to help recover white blood cell counts.
D: According to the guidelines, filgrastim should be stored in the refrigerator and allowing it to sit at room temperature for 2 hours could compromise its effectiveness. This is a deviation from the medication's storage requirements and could potentially harm the patient, thus an incident report should be filed.

Nursing Test Bank

Quiz #1: RN Exams Pharmacology Exams Quiz #2: RN Exams Medical-Surgical Exams Quiz #3: RN Exams Fundamentals Exams Quiz #4: RN Exams Maternal-Newborn Exams Quiz #5: RN Exams Anatomy and Physiology Exams Quiz #6: RN Exams Obstetrics and Pediatrics Exams Quiz #7: RN Exams Fluid and Electrolytes Exams Quiz #8: RN Exams Community Health Exams Quiz #9: RN Exams Promoting Health across the lifespan Exams Quiz #10: RN Exams Multidimensional care Exams

Get 100+ Naxlex Exit Exams for $79 Try Naxlex NCLEX-RN (14 Day Free-Trial)

Naxlex Comprehensive Predictor Exams

Quiz #1: Naxlex RN Comprehensive online practice 2019 B with NGN Quiz #2: Naxlex RN Comprehensive Predictor 2023 Quiz #3: Naxlex RN Comprehensive Predictor 2023 Exit Exam A Quiz #4: Naxlex HESI Exit LPN Exam Quiz #5: Naxlex PN Comprehensive Predictor PN 2020 Quiz #6: Naxlex VATI PN Comprehensive Predictor 2020 Quiz #8: Naxlex PN Comprehensive Predictor 2023 - Exam 1 Quiz #10: Naxlex HESI PN Exit exam Quiz #11: Naxlex HESI PN EXIT Exam 2

Free Nursing Study Resources

Correct Answer is B

Explanation

Choice A rationale:

Enoxaparin is administered subcutaneously, so the syringe needle should be fully inserted into the client's skin.

Choice B rationale:

Expelling the air bubble from the syringe helps ensure accurate dosage and prevents the injection of air into the subcutaneous tissue.

Choice C rationale:

Enoxaparin is administered subcutaneously, not into muscle tissue.

Choice D rationale:

Applying firm pressure to the injection site following administration is not typically necessary for subcutaneous injections of enoxaparin.

A. Pruritus B. Gastric bleeding C. Tachypnea D. Cough

Correct Answer is A

Explanation

Choice A rationale:

Pruritus, or itching, is a common adverse effect of opioid medications like morphine.

Choice B rationale:

Gastric bleeding is not a typical adverse effect of morphine administered via epidural infusion.

Choice C rationale:

Tachypnea, or rapid breathing, is not a common adverse effect of morphine. It's more commonly associated with opioid overdose.

Choice D rationale:

Cough is not a prominent adverse effect of morphine administered via epidural infusion.

View Question and Answer

Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.

Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today

A nurse recently administered filgrastim intravenously to a client who has ccer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?

Nursing Test Bank

Naxlex Comprehensive Predictor Exams

A nurse is preparing to administer enoxaparin to a client. Which of the following actions should the nurse take?

Correct Answer is B

Explanation

A nurse is planning care for a client who is receiving morphine via continuous epidural infusion. The nurse should monitor the client for which of the following adverse effects?

Correct Answer is A

Explanation

A nurse is providing teaching to a client who has a new prescription for paroxetine. The nurse should instruct the client to monitor for which of the following adverse effects?

A nurse is preparing to administer amphotericin B lipid complex via intermittent IV bolus to a client who has infective endocarditis. Which of the following actions should the nurse take?

A nurse is reviewing the laboratory results of a client who is taking amitriptyline. Which of the following laboratory values should the nurse report to the provider?

A nurse is reviewing the laboratory results of a client who is taking amitriptyline. Which of the following laboratory values should the nurse report to the provider?

A nurse is preparing to administer digoxin orally to a client. Identify the sequence of steps the nurse should take. (Move the steps placing them in the order of performance. Use all the steps.)

A nurse is administering naloxone to a client who has developed an adverse action to morphine. The nurse should identify which of the following findings as a therapeutic effect of naloxone?

A nurse is caring for a client who has heart failure and monitor when administering lisinopril?

A nurse is reviewing the laboratory data of a client prior to administering IV tobramycin. Which of the following laboratory values should the report to the provider?